Treatment specialists

Your PCP can spot early warning signs, support referrals, and keep your health on track between specialist visits.

PCPs and coordinated follow-up in IgG4-RD

For people with IgG4-related disease (IgG4-RD), life can start to feel like a calendar full of appointments with different specialists: rheumatology, gastroenterology, nephrology, radiology, lab tests, and medications. That can be confusing, and it’s exactly why coordination matters.

In many IgG4-RD care models, a rheumatologist coordinates the IgG4-RD plan. They direct the diagnostic work- up, bring in organ-specific specialists as needed, and guide tre atment and monitoring over time. In that sense, the rheumatologist is the “captain” for IgG4-RD decisions.

At the same time, your primary care practitioner (PCP) remains essential because they coordinate your overall health. They make it easier for the IgG4-RD plan to actually work in real life: day to day, between visits, and across insurance rules.

A patient’s story

Cecilia Wainoga’s story started when her primary care doctor noticed something wasn’t adding up. She had significant weight loss and then developed jaundice. Her PCP moved quickly to order imaging, which showed what looked like a “mass.” After the fear and uncertainty of that finding, further testing, including biopsy and expert review, helped clarify what was really happening.

Why PCPs must keep “mimics” in mind

IgG4-RD can imitate many other diseases, and that’s one reason it often takes so much time to diagnose. As a systemic condition, it can involve almost any organ and may appear as a mass-like (tumefactive) lesion on imaging, the same kind of finding that naturally raises concern for cancer. ^1,7

The GP’s role is often to guide you through the diagnostic stage, when doctors know something is wrong but don’t yet know exactly what it is. That means your GP helps make sure several important things happen:

• Rule out urgent causes quickly. If imaging shows a mass or an organ isn’t functioning well, the next steps may include repeat labs, expedited referral, and sometimes biopsy to rule out cancer or infection.⁷

• Push for the right specialist input. Depending on the organ involved, the GP helps route the patient to the best next specialist (often rheumatology, but sometimes GI, nephrology, pulmonology, ENT, or others).⁴

• Keep the story connected. The GP helps link symptoms, imaging, labs, and specialist notes so that a multisystem pattern is recognized rather than treated as unrelated problems.⁶

Helping patient get the right referrals

When symptoms are atypical, or when the initial evaluation isn’t giving clear answers, the next step is often a referral to a specialist.

Your PCP can initiate an appropriate referral and send a focused clinical summary. This helps the specialist evaluate the differential diagnosis, rule out key mimics, and determine the next diagnostic or treatment steps.

In practice, that can look like:

• A clear referral note summarizing red flags and key test results

• Directing you to the right specialist based on organ involvement

• Flagging the need for expert pathology review if a biopsy was already done

Because IgG4-RD care commonly spans multiple specialties, it also helps when the PCP ensures key results and updates are shared across the team, especially if symptoms change between visits

The PCP’s role during treatment

In most cases, your treating specialist (often a rheumatologist) leads the IgG4-RD plan and coordinates organ-specific referrals based on where the disease is active. Your PCP supports that plan by keeping your overall health stable, monitoring for treatment side effects, and helping the team stay connected between specialist visits.

What the rheumatologist usually leads

Your rheumatologist typically guides the decisions that are most specific to IgG4-RD:

• Decides whether treatment is needed now, and sets organ-specific goals

• Prescribes and adjusts IgG4-RD therapy (including steroid start and taper)

• Defines what counts as response vs flare (relapse) and when to escalate care

• Coordinates other specialists for organ-specific decisions and m onitoring

• Reassesses risk/benefit when the situation is less clear and “watchful waiting” is considered

What the PCP typically manages

The PCP typically manages whole-person care that supports the plan:

Monitoring for steroid toxicities: Tracking blood pressure, blood glucose/A1c, weight, mood/sleep changes, fluid retention, and infection symptoms, so emerging problems are caught early and treated promptly.²

Protecting bone and cardiometabolic health: Assessing osteoporosis risk, reinforcing bone-health basics, and coordinating bone density testing when indicated, especially for older adults or longer steroid courses.²

Managing other conditions steroids can worsen: Actively managing issues such as diabetes, hypertension, osteoporosis, glaucoma, and mood disorders, and adjusting non-IgG4 medications when needed.²

Supporting the taper plan and watching for flares: Helping patients track symptoms and any objective markers the specialist team is using, and encouraging quick reporting of possible flare signs rather than waiting for the next specialty visit.⁶

Coordinating prevention and infection risk planning: Supporting prevention steps, including vaccination planning and infection-risk counseling, especially when patients are moving toward steroid-sparing immunosuppression or B-cell–targeted therapy.⁸

What is “coordinated follow-up”?

Coordinated follow-up means your care team shares information, agrees on one plan, and checks in often enough to coordinated follow-up means your care team shares information, agrees on one plan, and checks in often enough to catch problems early, both those arising from the disease and those arising from any treatment side effects. In IgG4- RD, this matters because the disease can be quiet in some organs while still causing damage, and it can also mimic other serious illnesses.

Here’s what that coordination often includes look like:

Clear leadership for the IgG4-RD plan. Rheumatology generally outlines the disease management plan. The PCP helps implement it by monitoring the patient and troubleshooting between visits.⁴

Review of test results. The PCP helps make sure labs and imaging ordered by different specialists are seen, understood, and acted on by the right clinician. ⁶

Right-timed check-ins. Rheumatology defines the follow-up cadence; PCP helps keep the schedule on track and escalates new symptoms quickly. ²

Side effect surveillance. PCP monitors steroid effects and general health risks and feeds that information back to rheumatology. ²

Insurance coverage and prior authorizations. Depending on your insurance rules, your PCP may be the required “gatekeeper” who initiates referrals, places certain orders, or submits specific forms before specialist care or treatments will be approved. ¹⁰

Do all patients need treatment?

Not every person with IgG4-RD needs treatment that starts right away. In some situations, depending on the risks and benefits for that individual, the plan may be to treat now. In others, especially when disease seems limited, symptoms are mild, and no vital organs are threatened, the plan may be to monitor closely before starting therapy.⁸

What matters most is that “watching” is not the same as “doing nothing.” If treatment is deferred, the follow-up plan needs to be clear and reliable: what symptoms to report, w hich labs or imaging will be checked, and how often reassessment will happen, because ongoing inflammation can still lead to organ damage over time.⁸

This is a common situation in which the PCP becomes especially important. When the plan is “watch carefully,” the PCP helps make sure symptoms are monitored, changes are communicated early to the specialist team, and follow-up doesn’t drift or get delayed.⁶

Care coordination checklist

This is a short list of questions you (or your PCP) can use:

• Who is the lead doctor for my IgG4-RD plan right now?

• Which symptoms should trigger a same-week call?

• Which labs or imaging are we using to track disease, and how often?

• What treatment side effects should we watch for during tapering or immune therapy?

• How will test results be shared across the team?

When your care team answers these clearly, you may feel more reassured that your care is well coordinated across specialists.

Summary

Your PCP is a key partner in your IgG4-RD care, often the first clinician to recognize early warning signs and start the referral path. They can help you get to the right specialists and the right testing, especially when symptoms involve more than one organ system.

While specialists focus on the IgG4-RD, your PCP looks after the rest of your health – keeping an eye on things like infections, medication side effects, and long-term risks such as blood pressure, blood sugar, and bone health. Over time, they help coordinate follow-up so flares or complications are recognized early, and your overall care stays coherent and connected.

References

1. Stone JH, Zen Y, Deshpande V. IgG4-Related Disease. N Engl J Med. 2012;366:539–551. https://pubmed.ncbi.nlm.nih.gov/22316447

2. Massachusetts General Hospital, Rheumatology. IgG4-Related Systemic Disease Program (Treatments & Services page). MassGeneral.org. Accessed 2026-02-18. https://www.massgeneral.org/medicine/rheumatology/treatments-and-services/igg4

3. Arias-Intriago M, Gomolin T, Jaramillo F, et al. IgG4-Related Disease: Current and Future Insights into Pathological Diagnosis. Int J Mol Sci. 2025;26:5325. doi:10.3390/ijms26115325 https://pubmed.ncbi.nlm.nih.gov/40508133

4. IgG4ward! Foundation. It Takes a Team: The Specialists Who Support IgG4-RD. IgG4ward.org. Accessed 2026-02-18. https://igg4ward.org/igg4rd-care-team-specialists

5. Peyronel F, Della-Torre E, Maritati F, et al. IgG4-related disease and other fibro-inflammatory conditions. Nat Rev Rheumatol. 2025;21:275–290. doi:10.1038/s41584-025-01240-x https://pubmed.ncbi.nlm.nih.gov/40195520

6. IgG4ward! Foundation. Understanding IgG4-related disease (IgG4-RD). IgG4ward.org. Accessed 2026-02-18. https://igg4ward.org/understanding-igg4-related-disease-igg4-rd-2

7. Lang D, Zwerina J, Pieringer H. IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag. 2016;12:189–199. doi:10.2147/TCRM.S99985 https://pmc.ncbi.nlm.nih.gov/articles/PMC4760655

8. “IgG4-RD A conversation on Treatment_VF” (patient-treatment discussion excerpt provided by user; topics: who needs treatment, risks/benefits, follow-up, steroids, steroid-sparing therapy). https://www.youtube.com/watch?v=7vTUnlP-RAY

9. Mayo Clinic Staff. Autoimmune pancreatitis—Symptoms and causes (notes Type 1 AIP is IgG4-RD and can affect multiple organs; can mimic pancreatic cancer). MayoClinic.org. Updated 2023-12-16. https://www.mayoclinic.org/diseases-conditions/autoimmune-pancreatitis/symptoms-causes/syc-20369800

10. IgG4ward! Foundation. Navigating Insurance Barriers in IgG4-RD Care (IgG4-RD and Alliance for Patient Access). Published Aug 29, 2024. Accessed 2026-02-18. https://igg4ward.org/personal-igg4-rd-stories/igg4rd-and-alliance-for-patient-access